DAVION HEALTHCARE PLC

Davion Healthcare Plc is a healthcare technology company focused on developing early-warning, non-invasive Class I medical screening devices. Its product offerings include BreastCheck, an early indicator screening test utilizing thermochromic films, and FootFlow. The company operates through a licensing and distribution commercial model, partnering with regional and global licensees such as NeuRX Health Inc. to manage manufacturing, product marketing, retail distribution, customer support, and warranty obligations. Its target end users comprise individual consumers seeking preventative wellness insights as well as healthcare providers who review test results processed via smartphone applications and proprietary artificial intelligence servers.

The company is incorporated under the laws of the Republic of Ireland, maintaining its principal executive offices in Cork, Ireland. Product manufacturing designated for the North American market is situated in the United States, utilizing components sourced through local suppliers. As an emerging business, the enterprise has attained regulatory registration for initial offerings but has not launched commercial sales.

Summary of the business section of Davion Healthcare's latest annual report, written by StockData.